Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Semaglutide
History
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist developed to mimic the naturally occurring GLP-1 hormone. It was created to help regulate blood sugar and appetite and has become one of the most extensively studied GLP-1 therapies.
Research Use
Researchers study Semaglutide for its potential effects on:
Blood glucose regulation
Appetite control
Weight management
Cardiometabolic health
Insulin secretion
Gastric emptying
Clinical Highlights
Studied for improving blood sugar control by enhancing glucose-dependent insulin release
Investigated for promoting significant weight loss through appetite reduction and increased satiety
May improve cardiovascular and metabolic health in appropriate patient populations
Explored for reducing the risk of obesity-related complications
Research continues to evaluate its potential in additional metabolic and chronic disease conditions
Semaglutide
History
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist developed to mimic the naturally occurring GLP-1 hormone. It was created to help regulate blood sugar and appetite and has become one of the most extensively studied GLP-1 therapies.
Research Use
Researchers study Semaglutide for its potential effects on:
Blood glucose regulation
Appetite control
Weight management
Cardiometabolic health
Insulin secretion
Gastric emptying
Clinical Highlights
Studied for improving blood sugar control by enhancing glucose-dependent insulin release
Investigated for promoting significant weight loss through appetite reduction and increased satiety
May improve cardiovascular and metabolic health in appropriate patient populations
Explored for reducing the risk of obesity-related complications
Research continues to evaluate its potential in additional metabolic and chronic disease conditions